Shengliang Peng

发表

miR-103a-3p Could Attenuate Sepsis-Induced Liver Injury by Targeting HMGB1

Q. Lu, Chunfang Liu, Leifeng Chen, 2020, Inflammation.

L-theanine attenuates Isoflurane-induced Injury in Neural Stem Cells and Cognitive Impairment in Neonatal Mice.

Fang Lian, Q. Lu, Xiaohong Du, 2020, Biological & pharmaceutical bulletin.

Hsp22 pretreatment protects against LPS-induced hippocampal injury by alleviating neuroinflammation and apoptosis by regulating the NLRP3/Caspase1/IL-1β signaling pathway in mice

Lidong Wu, Danling Jiang, Guohai Xu, 2023, Aging.

miR-103a-3p Could Attenuate Sepsis-Induced Liver Injury by Targeting HMGB1

Q. Lu, Chunfang Liu, Leifeng Chen, 2020, Inflammation.

NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors

Jiali Hu, Shengliang Peng, Yi Xu, 2023, Translational Neurodegeneration.

Mechanotransductive receptor Piezo1 as a promising target in the treatment of fibrosis diseases

Jiali Hu, Shengliang Peng, Yi Xu, 2023, Frontiers in molecular biosciences.

Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment

Ziyan Hu, Shengliang Peng, Jinxi Zhu, 2024, Frontiers in endocrinology.

Future directions in ventilator-induced lung injury associated cognitive impairment: a new sight

Shengliang Peng, Yinuo Liu, Wei Luo, 2023, Frontiers in physiology.

Progress in the Pathogenesis of Diabetic Encephalopathy: The Key Role of Neuroinflammation.

Ziyan Hu, Shengliang Peng, Jinxi Zhu, 2024, Diabetes/metabolism research and reviews.

Role of the P2 × 7 receptor in neurodegenerative diseases and its pharmacological properties

Ziyan Hu, Shengliang Peng, Danling Jiang, 2023, Cell & bioscience.